Benitec Biopharma Inc

Research Benitec Biopharma Inc (BNTC) on Bullrun: market cap USD 436.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBNTC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 436.30M
• Financial periodFY2025
• Net income-USD 37.92M
• Free cash flow-USD 23.61M

Valuation Snapshot

latest market cap is USD 436.30M.

About Benitec Biopharma Inc

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct.

Frequently asked questions

What is Benitec Biopharma Inc's market cap?

Benitec Biopharma Inc's market capitalization is USD 436.30M.

What does Benitec Biopharma Inc do?

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing...